Skadden Reps Valeant In $3.2B Biovail Merger
By Melissa Lipman ( June 21, 2010, 5:00 PM EDT) -- Canada's Biovail Corp. agreed Monday to merge with California-based Valeant Pharmaceuticals International Inc. to form a new pharmaceutical giant under the Valeant name in a stock-and-cash deal worth more than $3.2 billion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.